MedTrace Logo

Accelerometer Sensing for Micra AV Study

NCT04245345 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2023-02-23

Study results available
· View outcomes & findings →

Summary

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

Conditions

  • AV Block
  • AV Block Complete
  • 3rd Degree Heart Block
  • Complete Heart Block

Interventions

DEVICE

Accelerometer Sensing for Micra AV Study

Characterize AV synchrony in subjects implanted with Micra AV device. The study will be conducted upon market approval of the Micra AV Transcatheter Pacing System.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Larry Chinitz, MD · NYU Langone

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2022-01-01
Completion
2022-01-10
FDA Device
Yes

Countries

  • United States
  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245345 on ClinicalTrials.gov